Clinical Trial Update: The Effect of Cyclofem® for the Treatment of Irregular Uterine Bleeding in Implant Contraceptive Users [Phase 1, Phase 2]

View source ↗

Summary

This document reports a Phase 1/2 clinical trial update evaluating Cyclofem for abnormal uterine bleeding in users of implant contraception.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abnormal Uterine Bleeding

Drugs mentioned

• Cyclofem (medroxyprogesterone acetate and estradiol benzoate)

Snippet

Sponsor: Chulalongkorn University | Conditions: Uterine Bleeding | Phase 1, Phase 2 | Status: UNKNOWN